IC View
The last IC recommendation on Shield Therapeutics PLC shares was Hold at 155.00 on 08 Aug 2019Read the full article
- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Notice of Results
- Unaudited Full Year Trading Update
- Appointment of new Chief Financial Officer
- Q3 2023 U.S. Commercial Highlights
- PDMR Transaction Notification
- Abstract to be presented at Healthcare Conference
- Chief Financial Officer Transition
- Result of REX Retail Offer
- Block listing Interim Return
- Completion of SWK Financing
More ▼
Key statistics
On Friday, Shield Therapeutics PLC (STX:LSE) closed at 1.35, 27.06% above the 52 week low of 1.06 set on Apr 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.23 |
---|---|
High | 1.40 |
Low | 1.40 |
Bid | 1.30 |
Offer | 1.40 |
Previous close | 1.23 |
Average volume | 3.47m |
---|---|
Shares outstanding | 782.06m |
Free float | 342.06m |
P/E (TTM) | -- |
Market cap | 10.56m GBP |
EPS (TTM) | -0.1549 GBP |
Data delayed at least 20 minutes, as of Apr 26 2024 17:06 BST.
More ▼